AIRLINK 201.50 Increased By ▲ 1.21 (0.6%)
BOP 10.47 Decreased By ▼ -0.02 (-0.19%)
CNERGY 7.20 Decreased By ▼ -0.01 (-0.14%)
FCCL 35.12 Increased By ▲ 0.18 (0.52%)
FFL 17.55 Increased By ▲ 0.13 (0.75%)
FLYNG 26.00 Increased By ▲ 1.15 (4.63%)
HUBC 129.94 Increased By ▲ 2.13 (1.67%)
HUMNL 13.96 Increased By ▲ 0.15 (1.09%)
KEL 5.06 Increased By ▲ 0.06 (1.2%)
KOSM 7.11 Increased By ▲ 0.08 (1.14%)
MLCF 45.05 Increased By ▲ 0.43 (0.96%)
OGDC 223.50 Increased By ▲ 1.35 (0.61%)
PACE 7.35 Decreased By ▼ -0.07 (-0.94%)
PAEL 43.25 Increased By ▲ 0.45 (1.05%)
PIAHCLA 17.35 Decreased By ▼ -0.04 (-0.23%)
PIBTL 8.65 Increased By ▲ 0.14 (1.65%)
POWER 9.17 Increased By ▲ 0.02 (0.22%)
PPL 194.00 Increased By ▲ 1.27 (0.66%)
PRL 41.36 Decreased By ▼ -0.14 (-0.34%)
PTC 24.37 Decreased By ▼ -0.07 (-0.29%)
SEARL 102.30 Increased By ▲ 1.03 (1.02%)
SILK 1.03 Decreased By ▼ -0.02 (-1.9%)
SSGC 44.40 Increased By ▲ 0.53 (1.21%)
SYM 18.63 Decreased By ▼ -0.13 (-0.69%)
TELE 9.58 Increased By ▲ 0.04 (0.42%)
TPLP 13.19 Increased By ▲ 0.11 (0.84%)
TRG 68.50 Increased By ▲ 2.31 (3.49%)
WAVESAPP 10.75 Increased By ▲ 0.22 (2.09%)
WTL 1.80 Increased By ▲ 0.02 (1.12%)
YOUW 4.08 Increased By ▲ 0.04 (0.99%)
BR100 12,123 Increased By 83.4 (0.69%)
BR30 37,097 Increased By 408.3 (1.11%)
KSE100 115,464 Increased By 660 (0.57%)
KSE30 36,310 Increased By 208.1 (0.58%)

ISLAMABAD: The government has started a crackdown on spurious and substandard drugs and has directed healthcare professionals, physicians, pharmacists, nurses, and procurement managers at hospitals, clinics, pharmacies, healthcare institutions and the general public to immediately stop using the products that are declared spurious by drug testing laboratories.

A notification issued here on Friday by the Drug Regulatory Authority of Pakistan (DRAP) while recalling the affected products has directed all the relevant quarters to stop using these products.

The Directorate of Drugs Control (DDC) Punjab vide Alert No 137/2024 has informed that the following samples of drug products have been declared as “Spurious” by Drug Testing Laboratories (DTL) Multan, Lahore, Rawalpindi, and Faisalabad.

Details of affected products are as follows:(i) Nutricare Syrup 450ml which is used for the treatment and prevention of different forms of anaemia batch number NC-457 produced by M/s Care Pharmaceuticals.

(ii) Velosef 500mg Capsule used to treat a wide variety of bacterial infections like skin, ear, respiratory and urinary tract infections batch number 447M manufactured by M/s GSK, Karachi.

(iii) Pyodine Solution 60m and Pyodine Solution 450ml used on the skin to treat or prevent skin infection in minor cuts, scrapes, or burns batch number 04813 and 08913 manufactured by M/s Brookes Pharma, Karachi.

(iv) Tanzo 0.5g injection is used to treat pneumonia (inflammation of air sacs in one or both lungs), skin, gynecological, and abdominal (stomach area) infections batch number PN220142 manufactured by M/s Bosch Pharmaceuticals, Karachi.

(v) Dygowin 10mg Tablet used to treat various conditions caused by progesterone deficiencies such as female infertility, pain during menstruation, premenstrual syndrome (PMS), endometriosis, abnormal uterine bleeding, and miscarriage batch number 736 manufactured by M/s Weather Fold Pharmaceuticals, Hattar, Haripur District, Khyber-Pakhtunkhwa.

(vi) Duphaston tablet is used to treat disorders related to the female reproductive cycle, infertility, irregular menses, and uterine bleeding batch number 230672 manufactured by Highnoon Laboratories Lahore and batch number 230092 by Abbott Laboratories, Karachi.

(vii) Cefspan 400mg Capsule used for the treatment of bacterial infections of the ear, nose or sinuses batch number D6780 M/s. Barrett Hodgson Pakistan, Karachi.

(viii) Phenobarb 30mg Tablet used to treat and prevent epilepsy batch number QA023 manufactured by M/s Star Laboratories, Lahore.

(ix) Powder Amox 500 (1kg) veterinary use imported by M/s Brand Station, Lahore batch number 0010823 Manufactured by M/s the North Star Import Export Joint Stock Company, Can Tho City, Vietnam.

The regulatory field force has been directed to increase surveillance throughout the supply chain system including healthcare facilities to confiscate/ seize this product from the market without any delay.

All Pharmacists, chemists, and other healthcare professionals working at distributions, pharmacies, healthcare facilities, and other aspects of the supply chain system should immediately check the stock to halt the distribution/ supply of this product.

Information related to the supplier of this product should be provided to the Regulatory field force (DRAP, Provincial Health Departments, and States) to ensure the removal of this product.

Consumers should stop using this product and shall contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product and report the incident to the DRAP/National Pharmaco vigilance Centre

All therapeutic goods must be obtained from licensed pharmacies and other authorised/ licensed retail outlets. The authenticity and condition of products should be carefully checked. Advice should be sought from pharmacists or other healthcare professionals in case of any doubt.

Copyright Business Recorder, 2024

Comments

Comments are closed.